The objective of the ongoing R&D in this domain is to develop novel CSC directed treatments that can combat complications, such as off-target toxicities and disease relapse, associated with the current standard of care treatments.TheCancer Stem Cell Therapies Market, 2017-2030report examines the current landscape and the future outlook of the growing pipeline of products targeting CSCs.Some of the most interesting insights from our study are presented below.
Recent Comments